Xiangfeng Zeng

发表

FGF9 inhibition by a novel binding peptide has efficacy in gastric and bladder cancer per se and reverses resistance to cisplatin.

Jizhong Wang, Xiangpeng Tan, Qiuxiao Guo, 2019, Pharmacological research.

A bFGF Antagonist Peptide with Anti-angiogenesis Properties in Non-small Cell Lung Cancer Cells

Yonglin Yu, Xiangfeng Zeng, Xiao-ping Wu, 2013, International Journal of Peptide Research and Therapeutics.

Inhibition of autophagy promotes apoptosis and enhances anticancer efficacy of adriamycin via augmented ROS generation in prostate cancer cells.

Qi Yang, Jizhong Wang, Xiangpeng Tan, 2016, The international journal of biochemistry & cell biology.

Identification of a crucial amino acid responsible for the loss of specifying FGFR1–KLB affinity of the iodinated FGF21

Xiao-mian Lin, Xiangfeng Zeng, Heng Wang, 2018, Journal of cellular physiology.

Topographical and Biological Evidence Revealed FTY720-Mediated Anergy-Polarization of Mouse Bone Marrow-Derived Dendritic Cells In Vitro

Xinqiang Lai, Xiangfeng Zeng, B. Song, 2012, PloS one.

FTY720 mediates activation suppression and G0/G1 cell cycle arrest in a concanavalin A-induced mouse lymphocyte pan-activation model

Tong Wang, Xinqiang Lai, Xiangfeng Zeng, 2012, Inflammation Research.

Identification of galectin-1 as a novel mediator for chemoresistance in chronic myeloid leukemia cells

Xiao-kun Li, Qi Yang, Jizhong Wang, 2016, Oncotarget.

P7 peptides targeting bFGF sensitize colorectal cancer cells to CPT-11.

Yonglin Yu, Xiangpeng Tan, Xiangfeng Zeng, 2014, International journal of molecular medicine.

Calcium influx blocked by SK&F 96365 modulates the LPS plus IFN-γ-induced inflammatory response in murine peritoneal macrophages.

Xinqiang Lai, Xiangfeng Zeng, Xiao-ping Wu, 2012, International immunopharmacology.

Identification of cofilin-1 as a novel mediator for the metastatic potentials and chemoresistance of the prostate cancer cells.

Xiangpeng Tan, Qiuxiao Guo, Xiao-mian Lin, 2020, European journal of pharmacology.

A short peptide derived from the gN helix domain of FGF8b suppresses the growth of human prostate cancer cells.

Xiaokun Li, Yonglin Yu, Yadong Huang, 2013, Cancer letters.

The anti-inflammatory effect of the SOCC blocker SK&F 96365 on mouse lymphocytes after stimulation by Con A or PMA/ionomycin.

Xinqiang Lai, Xiangfeng Zeng, Xiuyan Huang, 2011, Immunobiology.

Icaritin exhibits anti-inflammatory effects in the mouse peritoneal macrophages and peritonitis model.

Xinqiang Lai, P. Yin, Xiangfeng Zeng, 2013, International immunopharmacology.

Antitumor effect of a short peptide on p53-null SKOV3 ovarian cancer cells.

Qiuxiao Guo, Xiao-mian Lin, Yi-shan Huang, 2019, Anti-cancer drugs.

FTY720 mediates activation suppression and G0/G1 cell cycle arrest in a concanavalin A-induced mouse lymphocyte pan-activation model

Tong Wang, Xinqiang Lai, Xiangfeng Zeng, 2012, Inflammation Research.

A bFGF Antagonist Peptide with Anti-angiogenesis Properties in Non-small Cell Lung Cancer Cells

Yonglin Yu, Xiangfeng Zeng, Xiao-ping Wu, 2013, International Journal of Peptide Research and Therapeutics.

An FGF8b-mimicking peptide with potent antiangiogenic activity.

Qi Yang, Jizhong Wang, Xiao-mian Lin, 2017, Molecular medicine reports.

Hyperactivated FRS2α-mediated signaling in prostate cancer cells promotes tumor angiogenesis and predicts poor clinical outcome of patients

Y. Huang, Chin-Lee Wu, Yanqing Huang, 2016, Oncogene.

P7 peptides targeting bFGF sensitize colorectal cancer cells to CPT-11.

Yonglin Yu, Xiangpeng Tan, Xiangfeng Zeng, 2014, International journal of molecular medicine.

AMIGO2 attenuates innate cisplatin sensitivity by suppression of GSDME‐conferred pyroptosis in non‐small cell lung cancer

Xiangpeng Tan, Lian-kuai Chen, Xiangfeng Zeng, 2023, Journal of cellular and molecular medicine.